Clinical Trials Browser

OTHER × Observational × durvalumab × Clear all

NCT06634199 2026-01-28

SIENNA

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04364776 2023-09-28

Radiomic Signature as Predictive Marker of Response to Chemoradiation and Durvalumab in Stage III NSCLC.

Lung Neoplasms

NCT04107168 2023-02-16

Microbiome Immunotherapy Toxicity and Response Evaluation

DermatologicGenitourinaryThoracic

Kidney Neoplasms, Lung Neoplasms, Melanoma

NCT04359199 2023-02-10

QUASAR

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT04285866 2022-06-07

S-REAL

Lung Neoplasms, Small Cell Lung Carcinoma

NCT04672759 2020-12-17

A Real-world Study of Durvalumab for Lung Cancer in China

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma